ELV vs HUM
Elevance Health vs Humana — AI-powered side-by-side comparison
ELV
Elevance Health
69
Buy
VS
| Metric | ELV | HUM |
|---|
| AI Score |
69
|
68
|
| Price |
$400.25
|
$389.25
|
| P/E Ratio |
17.79×
|
36.53×
|
| ROE |
12.9%
|
6.7%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
39.0%
|
13.7%
|
| Debt / Equity |
0.69×
|
0.74×
|
| Dividend Yield |
1.7%
|
0.9%
|
| RSI (14) |
62.8
|
58.2
|
| Beta |
0.692
|
0.74
|
| Expected Upside |
+0.5%
|
+9.8%
|
AI Committee View
Current Innellis committee reasoning for ELV versus HUM.
ELV leads by 1 points.
ELV scores 69/100 (Buy) versus HUM at 68/100 (Buy).
ELV Committee View
80% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
HUM Committee View
75% agreement
4 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth